Medistim announces partnership with ROMA-Women Trial
Jun 5, 2023
Medistim is pleased to announce its partnership with ROMA-Women, a groundbreaking cardiac surgery trial that is specifically focused on women. Historically, cardiovascular research and treatment protocols have primarily focused on men, leaving women underrepresented in…
Medistim is opening a direct sales office in China
Apr 3, 2023
More than 60,000 coronary bypass procedures are performed in China annually and the number is expected to continue to grow high single digit in the years to come. Today, about 70% of these procedures are…
Medistim Expands Market Coverage in Canada by Going Direct
Mar 22, 2023
“We are excited to announce this strategic move that will strengthen our relationship with our customers in Canada and grow our business there,” – Medistim President and CEO Kari E. Krogstad
Capital Markets Day 2023
Feb 27, 2023
See the recording from Medistim's Capital Markets Day on March 21st where two international thought leaders, Professors John. D. Puskas and Pirkka Vikatmaa shared their insights on the future trends in Cardiac and Vascular Surgery…
Medistim celebrates a long-standing relationship with the Japanese cardiac surgery community
Dec 2, 2022
This is very much a story of a perfect fit between Norwegian technology and Japanese quality standards. Medistim technology has been able to meet expectations of the quality driven Japanese market. There are few arenas…
